COCA-COLA COMPANY
v.
DIXIE-COLA LABORATORIES, INC., ET AL.
COCA-COLA COMPANY
DIXIE-COLA LABORATORIES, INC., ET AL.
314 U.S. 629
Supreme Court of the United States (1941)
Positive Treatment
Cited by 12 cases
Opinion
Full opinion text not available for this case.
Cases With Similar Vibessemantic neighbors from the corpus
Citator
Cited By (12 total)
-
Cleo Syrup Corp. v. Coca-Cola Co., 139 F.2d 416 (8th Cir. 1943)…have said, it has acquired a secondary meaning in which perhaps the product is more emphasized than the producer but to which the producer is entitled.” See also Dixi-Cola Laboratories v. Coca-Cola Co., 4 Cir., 117 F. 2d 352, 354 (certiorari denied 314 U.S. 629, 62 S.Ct. 60. 86 L.Ed. 505). One certainly cannot be charged with misbranding or misdescribing a product by calling it what it is. There is no merit in the contention that a court of equity will not afford protection to the plaintiff’s trade-mark or…
-
Humble OIL & Ref. Co. v. Am. OIL Co., 405 F.2d 803 (8th Cir. 1969)…1936), cert. denied, 299 U.S. 601, 57 S.Ct. 194, 81 L.Ed. 443, and 304 U.S. 575; King-Seeley Thermos Co. v. Aladdin Indus., Inc., 321 F. 2d 577 (2 Cir. 1963); Dixi-Cola Laboratories, Inc. v. Coco-Cola Co., 117 F. 2d 352 (4 Cir. 1941), cert. denied, 314 U.S. 629, 62 S.Ct. 60, 86 L.Ed. 505; Kellogg Co. v. National Biscuit Co., 305 [*820] U.S. 111, 59 S.Ct. 109, 83 L.Ed. 73 (1938). In these cases the name contested had become the generic or popular term for the article in question. This was so even though th…
-
Thompson Med. Co., Inc. v. Pfizer Inc., 753 F.2d 208 (2d Cir. 1985)…showing of secondary meaning, courts increasingly have been called upon to delineate the chimerical line between the descriptive and the generic. See, e.g., Dixi Cola Laboratories, Inc. v. Coca-Cola, Co., 117 F. 2d 352, 360 (4th Cir.), cert. denied, 314 U.S. 629, 62 S.Ct. 60, 86 L.Ed. 505 (1941). . Of course, if a mark is classified as descriptive, courts must first examine a variety of factors to determine whether the mark has acquired secondary meaning, and is therefore eligible for protection. . We rec…
Previewing 3 of 12 citing cases — full citator treatment, depth of discussion, and citing context are member features.
Join FLexlaw to unlock all legal intelligence